Death by TNF: a road to inflammation

G Van Loo, MJM Bertrand - Nature Reviews Immunology, 2023 - nature.com
Tumour necrosis factor (TNF) is a central cytokine in inflammatory reactions, and biologics
that neutralize TNF are among the most successful drugs for the treatment of chronic …

IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

B Verstockt, A Salas, BE Sands, C Abraham… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-12 (IL-12) and interleukin-23 (IL-23), which belong to the IL-12 family of
cytokines, have a key role in intestinal homeostasis and inflammation and are implicated in …

Effect of therapeutic drug monitoring vs standard therapy during maintenance infliximab therapy on disease control in patients with immune-mediated inflammatory …

SW Syversen, KK Jørgensen, GL Goll, MK Brun… - Jama, 2021 - jamanetwork.com
Importance Proactive therapeutic drug monitoring (TDM), consisting of individualized
treatment based on scheduled assessments of serum drug levels, has been proposed as an …

The involvement of TH17 cells in the pathogenesis of IBD

P Jiang, C Zheng, Y **ang, S Malik, D Su, G Xu… - Cytokine & growth factor …, 2023 - Elsevier
The pathogenesis of inflammatory bowel disease (IBD) is still unclear. Immune dysfunction
may play a key role in the pathogenesis of IBD, in which the role of CD4+ T helper (Th) cells …

Immunology of inflammatory bowel disease: molecular mechanisms and therapeutics

Q Lu, M Yang, Y Liang, J Xu, H Xu, Y Nie… - Journal of …, 2022 - Taylor & Francis
As a main digestive organ and an important immune organ, the intestine plays a vital role in
resisting the invasion of potential pathogens into the body. Intestinal immune dysfunction …

Anti–tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease

I Peter, M Dubinsky, S Bressman, A Park, C Lu… - JAMA …, 2018 - jamanetwork.com
Importance Despite established genetic and pathophysiologic links between inflammatory
bowel disease (IBD) and Parkinson disease (PD), clinical data supporting this association …

[HTML][HTML] Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response

DA Elhag, M Kumar, M Saadaoui, AK Akobeng… - International journal of …, 2022 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic immune-mediated inflammation of the
gastrointestinal tract with a highly heterogeneous presentation. It has a relapsing and …

[HTML][HTML] Vedolizumab, adalimumab, and methotrexate combination therapy in Crohn's disease (EXPLORER)

JF Colombel, RC Ungaro, BE Sands, CA Siegel… - Clinical …, 2024 - Elsevier
Background & Aims Although biologics have revolutionized the treatment of Crohn's disease
(CD), an efficacy ceiling has been reached. Combining biologic therapies may improve …

Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies

R Akbar, H Bashour, P Rawat, PA Robert, E Smorodina… - MAbs, 2022 - Taylor & Francis
Although the therapeutic efficacy and commercial success of monoclonal antibodies (mAbs)
are tremendous, the design and discovery of new candidates remain a time and cost …

Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies

B Ahluwalia, L Moraes, MK Magnusson… - Scandinavian journal of …, 2018 - Taylor & Francis
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal
tract with a multifactorial pathophysiology. Full comprehension of IBD pathology is still out of …